Subject: Employment Verification - Poonam Chawla - Confidential
From: Supriya Nair <[email-masked]>
To: "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>
Date: Fri, 18 Jun 2021 10:04:18 +0000

Dear HR Team,

Greetings!

First Advantage Private Limited is acting on behalf of a Client with context to Employment Screening Services.

Request you to verify the following information provided by Poonam Chawla  who claims his employment with your esteemed organization "Cherry E-Commerce Services Private Limited"

Details
Details provided by the Candidate
Details provided as per company records
FADV Reference Number
159557644
Name
Poonam Chawla
Company Address
(Please specify the current address with nearest landmark)
Company Landline number
(Please specify the board line and direct contact number)
Employee Code
(Please Specify)
(PLEASE VERIFY)
Date Employed (From)
May/31/2017
(If this is incorrect, please provide the correct period of  employment) - mm/dd/yy
Date Employed (To)
May/25/2019
(If this is incorrect, please provide the correct period of  employment) - mm/dd/yy
Designation
Customer Service Executive (German Language)
(In case of disconnect, please specify if the designations are at par)
Reason for leaving
Met with an accident twice
(Please specify the reason)
Exit formalities completed?(If No, from whose side?)
(Please Specify)
Eligible for rehire (Based on job performance)
(If no, kindly specify the reason)
Is the document authentic? (Please specify Yes/No)
Experience letter
(If no, please specify the discrepancy)
Verified by (Name, Designation and Department)
(Please Specify)

I would be highly obliged if you could verify the above details and revert at the earliest.

Your input is greatly valued. Looking forward to your co-operation.

Have a nice day.

Supriya Nair |Senior Operations Analyst - Operations
O: +91 022-40017851 | E: [email-masked]<mailto:[email-masked]>
We Are Your First Advantage | www.fadv.com<https://apc01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.fadv.com%2F&data=04%7C01%7Chr_induction%40intaspharma.com%7C563047dcb1ab40fbaa2308d88c3927ee%7Cba94d90fc1044d2c8bd97418cf188dcb%7C0%7C0%7C637413524589213207%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=VjbnzLDQ2kGf%2BBeIBzU1boENG9DT5%2FTsXyt3K%2BSMQIQ%3D&reserved=0>
<https://apc01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fclicktime.symantec.com%2F3LgysQUxAzNfqasxZPNHQgA7Vc%3Fu%3Dhttps%253A%252F%252Fwww.facebook.com%252FFirstAdvantage1&data=04%7C01%7Chr_induction%40intaspharma.com%7C563047dcb1ab40fbaa2308d88c3927ee%7Cba94d90fc1044d2c8bd97418cf188dcb%7C0%7C0%7C637413524589223202%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=L0JHWYvpH2n97U2MCzzn0S6JdM0ssBdpKG4I5k2c%2Fdk%3D&reserved=0>   <https://apc01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fclicktime.symantec.com%2F3STZqCiF7RfRuDn1Ka7mRzN7Vc%3Fu%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Ffirst-advantage%252F&data=04%7C01%7Chr_induction%40intaspharma.com%7C563047dcb1ab40fbaa2308d88c3927ee%7Cba94d90fc1044d2c8bd97418cf188dcb%7C0%7C0%7C637413524589233197%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=dZY07n2wbZJspyxSMqq5QqEujYTYjpx6d6WabBvBzXg%3D&reserved=0>    <https://apc01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fclicktime.symantec.com%2F3XBMiFvokNwubPGrtAvLAxi7Vc%3Fu%3Dhttps%253A%252F%252Ftwitter.com%252FFirstAdvantage&data=04%7C01%7Chr_induction%40intaspharma.com%7C563047dcb1ab40fbaa2308d88c3927ee%7Cba94d90fc1044d2c8bd97418cf188dcb%7C0%7C0%7C637413524589233197%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=naLiq9bTGzk6yqus74MQCrdSHuwsDd7aSIf%2F5h4G7Es%3D&reserved=0>    <https://apc01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fclicktime.symantec.com%2F3LUWLpzRHiU2C9ZZuEeQ3vS7Vc%3Fu%3Dhttps%253A%252F%252Fwww.instagram.com%252Ffirst_advantage%252F&data=04%7C01%7Chr_induction%40intaspharma.com%7C563047dcb1ab40fbaa2308d88c3927ee%7Cba94d90fc1044d2c8bd97418cf188dcb%7C0%7C0%7C637413524589243195%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=pkZaBVVlCooMXm1quQICC%2Bm%2FSJzVJGS8ZDurPXMuTj4%3D&reserved=0>    <https://apc01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fclicktime.symantec.com%2F3K2prdASxpX7hgX8Jdne9Ax7Vc%3Fu%3Dhttps%253A%252F%252Fwww.youtube.com%252Fuser%252FFirstAdantage1&data=04%7C01%7Chr_induction%40intaspharma.com%7C563047dcb1ab40fbaa2308d88c3927ee%7Cba94d90fc1044d2c8bd97418cf188dcb%7C0%7C0%7C637413524589243195%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=rP3KLITuRRT%2FcPDoTZ06VpDHJv9BNcyZ9%2B1jVV6%2BFRo%3D&reserved=0>
For any feedback & 1st level of escalation please contact [email-masked]<mailto:[email-masked]>
For 2nd level of escalation please contact [email-masked]<mailto:[email-masked]>